Pregnant Woman Clinical Trial
— ASSISTOfficial title:
The BD Odon DeviceTM for Assisted Vaginal Birth: a Feasibility Study to Investigate Safety and Efficacy
Besancon ASSIST study will investigate if the BD Odon DeviceTM is safe, effective and acceptable to women and maternity staff for assisted vaginal birth.
Status | Recruiting |
Enrollment | 104 |
Est. completion date | June 15, 2022 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - The woman is =18 years of age - The woman has a singleton pregnancy - The pregnancy is =28+0 weeks' gestation - There is a negative antenatal screen for HIV and Hepatitis B Exclusion Criteria: - The woman does not fulfil all of the inclusion criteria listed - There is a diagnosis of a fetal skull abnormality precluding AVB (i.e. macrocephaly) - There is a known osteogenesis imperfecta affected pregnancy - There is suspicion of a fetal bleeding disorder (von Willebrand's disease, AITP, haemophilia) - There is an intrauterine fetal death in the current pregnancy - The woman is sensitive to latex - The woman is currently serving a prison sentence - The woman lacks capacity to consent - The woman has a lack of ability to read or understand French as this would preclude successful completion of questionnaires - The woman has received intramuscular or intravenous opiates (i.e. pethidine or morphine) within the past 6 hours - The woman is in established labour (= 4cm cervical dilatation) without regional analgesia in place |
Country | Name | City | State |
---|---|---|---|
France | Chu Besancon | Besançon |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Besancon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of births successfully assisted with the BD Odon Device | Successful vaginal birth with the BD ODON DeviceTM: successful BD Odon assisted birth in the absence of maternal and neonatal serious adverse reactions | 3 months after delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05945225 -
Pregnancy Women and Individual Oral Prophylaxis in the Control of Gingival Inflammation (PRE-IOP)
|
N/A | |
Not yet recruiting |
NCT05821764 -
Investigation of the Passage of Antiviral Antibodies From Mother to Child
|
||
Not yet recruiting |
NCT06419192 -
Modifying Nutrition to Modify Delivery in Nulliparous Women
|
N/A | |
Completed |
NCT04620993 -
Biomechanical and Viscoelastic Properties of Plantar Fascia in Pregnant Women
|
||
Completed |
NCT03834805 -
Monitoring of Fetal Lung Elasticity by Elastography Between 24 and 39 Weeks
|
N/A | |
Recruiting |
NCT04898192 -
Monitoring of Incidence of Mental Discomfort in Pregnant Women During the Serious COVID-19 Pandemic Conditions
|
||
Completed |
NCT04769375 -
Pelvic Girdle Pain in Pregnant Women
|